Core Viewpoint - Zhejiang Jinhua New Materials Co., Ltd. (Jinhua New Materials) is preparing for its listing on the Beijing Stock Exchange, focusing on the production and sales of fine chemical products, particularly oxime series chemicals. The company has shown revenue growth in recent years, but its profitability remains a concern due to a significant drop in gross margin and net profit compared to 2021 [2][4][5]. Financial Performance - Jinhua New Materials reported revenues of 9.94 billion, 11.15 billion, and 12.39 billion for 2022, 2023, and 2024 respectively, with net profits of 0.78 billion, 1.73 billion, and 2.06 billion [4][5]. - The company’s revenue in 2021 was 11.53 billion, indicating a decline in 2022 by 1.59 billion. The net profit in 2021 was 2.45 billion, which is more than three times the profit in 2022 [4][5]. - Gross margin dropped from 34.12% in 2021 to 17.72% in 2022, rebounding to 27.65% in 2023, but still below the 2021 level [5][6]. Industry Comparison - Jinhua New Materials' gross margin has consistently been lower than its peers. In 2022, the average gross margin for comparable companies was 34.59%, while Jinhua's was only 17.72% [6][7]. - The gross margin for Jinhua's main product, silane crosslinking agents, was 16.21% in 2022, significantly lower than the average of 34.88% for similar products from competitors [8][9]. Related Procurement and Financial Concerns - The company has faced scrutiny regarding the fairness of its related-party procurement, particularly concerning the pricing of raw materials [3][10]. - The proportion of receivables settled through bank acceptance bills increased significantly in 2024, raising concerns about the authenticity of the company's financial performance [3][12]. - Jinhua New Materials' cash flow from operating activities has shown significant volatility, with a notable decline of 68.74% in 2024 compared to 2023 [10][12]. Conclusion - Jinhua New Materials is experiencing a recovery in revenue but faces challenges in profitability and cash flow management. The reliance on bank acceptance bills for settlements and the low gross margins compared to industry peers raise questions about the sustainability of its financial performance [15].
锦华新材IPO:应收票据成倍暴增现金流吃紧,竞争对手停产留下的“盈利好日子”一去不复返
Sou Hu Cai Jing·2025-07-03 01:59